Effect of osteoprotegerin in postmenopausal women with diabetic osteoporosis

裘静英,李成江,董志春,沈建江
2013-01-01
Abstract:Objective To investigate the difference of serum osteoprotegerin (OPG) levels between primary osteoporosis and diabetic osteoporosis. Methods One hundred twenty natural postmenopausal women were enrol ed in the study, including 30 diabetic patients with osteoporosis, 30 diabetic patients without osteoporosis, 30 non- diabetic patients with osteoporosis and 30 non- diabetic women without osteoporosis. Serum OPG levels were measured by enzyme- linked immunosorbent assay (ELISA). Results OPG levels in non- diabetic patients with osteoporosis were higher than those in non- diabetic women without osteoporosis (P<0.01). OPG levels in diabetic patients with osteoporosis were higher than those in diabetic patients without os-teoporosis(P<0.05). OPG levels in diabetic patients with osteoporosis were higher than those in non- diabetic patients with osteo-porosis(P<0.05). OPG levels in diabetic patients without osteoporosis were higher than those in non- diabetic women without os-teoporosis (P<0.01). OPG levels were positively correlated with HbA1c and FPG levels (r=0.89 and 0.67, respectively;P<0.05). Conclusion Diabetic patients with osteoporosis have higher levels of serum OPG, indicating that OPG may be associated with di-abetic osteoporosis in postmenopausal women. The increased HbA1c levels in diabetic patients with osteoporosis indicate that the control of blood glucose may be important for prevention of diabetic osteoporosis.
What problem does this paper attempt to address?